Location
San Francisco, CA
Holdings as of
6/30/2026
Date filed
8/13/2026
Form type
13F-HR
Num holdings
13
Total value ($000)
$307,788
Net value change ($000)
+28,010 (10.0%)
New positions
1
Sold out positions
1
Turnover %
10.4%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 5/14/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
AVALYN PHARMACEUTICALS INC 31,827 NEW
TRVI 13,965 75.3%
MPLT 9,483 76.3%
BIOA 4,586 40.1%
AVTX 3,603 81.6%
PCVX 3,111 3.9%
RLYB 2,113 78.4%
ARQT 1,231 3.9%
ZBIO 883 7.6%
RXRX 358 19.6%
Top Reduces (Value $000, Stocks/ETFs)
OCS -23,787 -53.2%
EVMN -18,691 -42.2%
IMNM -498 -3.1%
BOLT -172 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type